Trans-femoral Amputation denials in California external review

In the California DMHC record, independent physician reviewers decided 18 published external-review cases involving trans-femoral amputationand overturned the plan’s denial in 50%. That is a historical result among cases that reached this program, not a forecast for an individual appeal.

California DMHC decisions
18
2005–2025
Overturned
50%
9 denials reversed

What the insurer actually argued

Denials fall into different categories, and they don’t succeed equally — so the reason on your letter changes how you should answer it.
Reason givenDecisionsOverturned
Medical Necessity
The plan said the care wasn’t medically necessary. The most common fight, and the most winnable.
14
42.9%
Experimental/Investigational
The plan called the treatment unproven. These turn on published evidence, so the appeal is a literature argument.
4
75%
Typical time to a decision
21 days
Most land between 16 and 22 days
Handled as urgent
22.2%
Expedited when a delay would cause harm

What the reviewers wrote

Excerpts from the independent reviewers’ published findings — the actual reasoning, quoted, not summarised.

Where the denial was overturned

Findings: The physician reviewer found that The patient requested authorization and coverage for a Ossur Rheo microprocessor knee and Ottoback Maverick Comfort AT prosthetic foot.Current literature regarding the benefits of microprocessor-aided prosthetic knees relative to prosthetic knees without microprocessor-aided control is largely mixed and based on small patient numbers with low-quality data. A study indicated that there is a lack of high quality evidence showing improvement with microprocessor-aided prosthetic knee devices on the risk of falls and gait parameters over prosthetic knee devices without computer control. Further, the studies promoting motor-processor controlled knees are of low quality.
Medical Necessity · 2023 · IMR MN23-39039
Nature of Statutory Criteria/Case Summary: The patient has requested authorization and coverage for endoskeletal knee/shin system with microprocessor control. There is a growing body of medical literature to support the use of microprocessor-controlled prosthetic knees for certain patient groups. Researchers note that the benefits of microprocessor-controlled prosthetic knees (MPKs) have been well established in community ambulators with a transfemoral amputation (TFA). The authors noted that a literature review suggests that limited community ambulators may also benefit from using an MPK in safety, performance-based function and mobility, and perceived function and satisfaction.
Medical Necessity · 2023 · IMR MN23-40240

Where the denial was upheld

Worth reading too — these show what an appeal has to overcome.
Nature of Statutory Criteria/Case Summary: The patient has a history of multiple chronic medical conditions, including arthropathy, for which he underwent a total left knee replacement in the past. This was complicated by an infection, and he ultimately underwent a left transfemoral amputation on 11/1/11. The patient underwent rehabilitation, including prosthetic ambulation training. He received a `preparatory` endoskeletal prosthesis in or around 2011 with an Ossur Symbionic (microprocessor-aided) knee, but he reportedly gained weight and could no longer use this prosthesis. Case management notes indicate that he received a replacement prosthesis in 2013 due to a weight gain of approximately 80 lbs. On 9/17/18, his provider noted that he is a current smoker of 11-20 cigarettes per day.
Medical Necessity · 2019 · IMR MN19-30661
Physician 1: The patient is a 24-year-old female who is status post right trans-femoral amputation following a motor vehicle accident in 2001. Her physician states the patient has used a wheelchair since the accident due to the fact that her limb is too short for a prosthesis. Her physician also indicates the patient underwent revision of the residual limb in October 2004 and has recovered well enough to allow her to use a prosthesis. The patient’s physician has recommended the patient receive an Otto-Bock C-leg prosthesis.There are no case-controlled, randomized studies demonstrating the superiority or improved functional outcomes of the Otto-Bock C-leg prosthesis compared to standard prosthetics.
Experimental/Investigational · 2005 · IMR EI05-4692

Figures and quotations on this page come from 42,749 published decisions in the California DMHC Independent Medical Review dataset. These are California external-review outcomes. Other state and federal programs have different eligibility rules, processes, and current availability; the rates here do not transfer to those programs or predict an individual result. Excerpts are quoted verbatim from the public record and describe this condition generally, not any individual case.

How to use this in your appeal

These outcomes describe eligible cases completed through California DMHC’s Independent Medical Review program. They do not estimate the chance that an internal appeal, an external review in another jurisdiction, or your individual case will succeed. Use the record to identify evidence patterns involving trans-femoral amputation, then check the rights and deadlines that apply to your plan.

SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · AGGREGATES + DEIDENTIFIED DECISION EXCERPTS/REFERENCE IDS · METHODOLOGY

Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.

Fighting a denial for trans-femoral amputation? Use the California record to prepare.

Explain my denial — freeStart my appeal · $9